Issue 23, 2024

Understanding the adsorption performance of hetero-nanocages (C12–B6N6, C12–Al6N6, and B6N6–Al6N6) towards hydroxyurea anticancer drug: a comprehensive study using DFT

Abstract

Cancer is a paramount health challenge to global health, which forms tumors that can invade nearby tissues and spread to neighboring cells. Recently, nanotechnology has been used to control the growth of cancer, in which anticancer drugs are delivered to cancerous cells via nanoparticles without damaging healthy tissues. In this study, DFT investigations were carried out to examine the adsorption behavior of C24, B12N12, and Al12N12 nanocages as well as their heterostructures C12–B6N6, C12–Al6N6, and B6N6–Al6N6 towards the hydroxyurea (HU) anticancer drug. In this regard, adsorption energy, interaction distance between the drug and nanocages, charge transfer, energy gap, dipole moment, quantum molecular descriptors, work function, and COSMO surface analysis were analyzed to understand their adsorption performance. Findings demonstrate that the adsorption energies of two hetero-nanocages on their hexagonal (SH) and tetragonal (ST) sites are favorable for the drug delivery process. The computed adsorption energy of B6N6–Al6N6 of the ST/AlN site is 183.59 kJ mol−1, which is higher than that of the C12–Al6N6 nanocage, including minimum adsorption distances. Negative adsorption energy with low adsorption distances implies an attractive interaction between the drug and nanocages. During the interaction, a significant amount of charge is transferred between the drug and nanocages. Furthermore, for both complexes, larger dipole moments were observed in water media compared to gas media. From DOS spectra, prominent peaks were found in the Fermi level after adsorption of HU on the nanocages, implying the reduction of the energy gap. Noticeable overlaps between the PDOS spectra of the nanocages and HU's close contact atom demonstrate the formation of chemical bonds between two specific atoms. Therefore, it can be concluded that among the nanocages, C12–Al6N6 and B6N6–Al6N6 may be suitable carriers for HU drug.

Graphical abstract: Understanding the adsorption performance of hetero-nanocages (C12–B6N6, C12–Al6N6, and B6N6–Al6N6) towards hydroxyurea anticancer drug: a comprehensive study using DFT

Article information

Article type
Paper
Submitted
07 Jun 2024
Accepted
08 Sep 2024
First published
03 Oct 2024
This article is Open Access
Creative Commons BY-NC license

Nanoscale Adv., 2024,6, 5988-6007

Understanding the adsorption performance of hetero-nanocages (C12–B6N6, C12–Al6N6, and B6N6–Al6N6) towards hydroxyurea anticancer drug: a comprehensive study using DFT

M. R. Swarna, M. H. Opi, T. Ahmed, A. A. Piya, U. Habiba and S. U. D. Shamim, Nanoscale Adv., 2024, 6, 5988 DOI: 10.1039/D4NA00472H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements